.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKesson
Federal Trade Commission
Mallinckrodt
Covington
UBS
Julphar
Baxter
Accenture
AstraZeneca

Generated: June 24, 2017

DrugPatentWatch Database Preview

Levofloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for levofloxacin and what is the scope of levofloxacin patent protection?

Levofloxacin
is the generic ingredient in six branded drugs marketed by Rising Pharms Inc, Orchid Hlthcare, Hetero Labs Ltd V, Dr Reddys Labs Inc, Jubilant Generics, Aurobindo Pharma Ltd, Janssen Pharms, Torrent Pharms, Lupin, Watson Labs Teva, Claris, Sandoz, Macleods Pharms Ltd, Acs Dobfar Info Sa, Akorn, Glenmark Generics, Zydus Pharms Usa Inc, Sagent Pharms, Teva, Wockhardt, Santen, Fresenius Kabi Usa, Hikma Farmaceutica, Mylan, Hospira Inc, Hi Tech Pharma, Apotex Inc, Watson Labs Inc, Emcure Pharms Ltd, and Cipla Ltd, and is included in forty-one NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for levofloxacin. Sixty-three suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: levofloxacin

Tradenames:6
Patents:2
Applicants:30
NDAs:41
Drug Master File Entries: see list28
Suppliers / Packagers: see list63
Bulk Api Vendors: see list56
Clinical Trials: see list175
Patent Applications: see list5,795
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levofloxacin at DailyMed

Pharmacology for Ingredient: levofloxacin

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Tentative approvals for LEVOFLOXACIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MG/MLINJECTABLE; INJECTION
► Subscribe► Subscribe250MGTABLET; ORAL
► Subscribe► Subscribe750MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd V
LEVOFLOXACIN
levofloxacin
TABLET;ORAL202801-003Jan 8, 2015ABRXNoNo► Subscribe► Subscribe
Jubilant Generics
LEVOFLOXACIN
levofloxacin
TABLET;ORAL203613-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe
Hospira Inc
LEVOFLOXACIN
levofloxacin
INJECTABLE;INJECTION078577-001Aug 12, 2015DISCNNoNo► Subscribe► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-003Sep 8, 2000ABRXYesYes► Subscribe► Subscribe
Torrent Pharms
LEVOFLOXACIN
levofloxacin
TABLET;ORAL090722-003Jun 20, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: levofloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-002Dec 20, 19964,382,892► Subscribe
Santen
IQUIX
levofloxacin
SOLUTION/DROPS;OPHTHALMIC021571-001Mar 1, 20045,053,407► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-003Sep 8, 20005,053,407*PED► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
INJECTABLE;INJECTION020635-001Dec 20, 19964,382,892► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
SOLUTION;ORAL021721-001Oct 21, 20045,053,407*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Citi
Boehringer Ingelheim
Julphar
Mallinckrodt
Chubb
Deloitte
Dow
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot